Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2010
06/29/2010US7745451 2,3-Difluoro-benzyl)-[6-(5-methyl-pyridin-2-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-yl]-amine, useful for the prevention and treatment of pain, inflammation, cognitive disorders, anxiety and depression in humans
06/29/2010US7745449 Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use
06/29/2010US7745442 Methods of reducing risk of infection from pathogens
06/29/2010US7745440 Pyrazole analogs acting on cannabinoid receptors
06/29/2010US7745436 Disalt inhibitors of IL-12 production
06/29/2010US7745434 1-[4-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-8-yl)phenyl]-3-(5-tert-butylisoxazol-3-yl)urea; treatment of tyrosine kinase-induced diseases and conditions, such as angiogenesis, cancer, tumour formation, growth and propagation, arteriosclerosis, ocular diseases, such as age-induced macular degeneration
06/29/2010US7745433 2-Substituted phenyl-5, 7-dihydrocarbyl-3, 7-dihydropyrrolo [2, 3-D] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
06/29/2010US7745377 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
06/29/2010CA2557856C 3-'4-heterocyclyl-1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
06/29/2010CA2455987C Tetrahydroindolone and purine derivatives linked to arylpiperazines
06/29/2010CA2345985C Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives,processes for their preparation, pharmaceuticals comprising these compounds and their use
06/24/2010WO2010071837A1 Pyrazine derivatives useful as inhibitors of atr kinase
06/24/2010WO2010070068A2 Organic compounds
06/24/2010WO2010070032A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
06/24/2010WO2010070022A1 Novel compounds
06/24/2010WO2010069949A1 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
06/24/2010WO2010069882A1 Isoxazole derivatives for use as fungicides
06/24/2010WO2010069881A2 Isoxazole derivatives for use as plant growth regulators
06/24/2010WO2010069833A1 Pyrimidin- 2 -ylamino derivatives and their use to treat inflammation
06/24/2010WO2010069266A1 Heterocyclic nitrogenous or oxygenous compounds with insecticidal activity formed from dialdehydes and their preparation and uses thereof
06/24/2010WO2010069147A1 Dihydropyrimidine derivatives, compositions thereof and their use
06/24/2010WO2010069069A1 Cathepsin b inhibitors
06/24/2010WO2010028159A3 Transition metal-catalyzed c-h amination using unactivated amines
06/24/2010US20100160629 Cyclic amide derivative, and its production and use
06/24/2010US20100160379 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
06/24/2010US20100160346 Neurologically active compounds
06/24/2010US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160336 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors
06/24/2010US20100160328 New compounds useful for dpp-iv enzyme inhibition
06/24/2010US20100160325 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
06/24/2010US20100160324 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
06/24/2010US20100160323 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
06/24/2010US20100160322 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
06/24/2010US20100160321 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase
06/24/2010US20100160320 C5aR ANTAGONISTS
06/24/2010US20100160319 Histamine h3 receptor agents, preparation and therapeutic uses
06/24/2010US20100160318 3-Pyrrolo[b]Cyclohexylene-2-Dihydroindolinone Derivatives and Uses Thereof
06/24/2010US20100160317 2-(2-oxoindoline-3-ylidene)methyl-5-(2-hydroxy-3-morpholin-4-yl-propyl)-6,7-dihydro-1h-pyrrol[3,2-c]pyridine-4(5h)-one compounds and use as protein kinase inhibitors
06/24/2010US20100160316 Quinazolines useful as modulators of ion channels
06/24/2010US20100160315 Novel 2, 3-diamino-quinazolinone derivatives and their medical use
06/24/2010US20100160314 Small Molecule Inhibitors of Toll-Like Receptor 9
06/24/2010US20100160313 Discovery of novel anticancer compounds based on conformational sampling of quinoxalinhydrazide pharmacophore
06/24/2010US20100160312 Substituted Pyridone Compounds and Methods of Use
06/24/2010US20100160311 Fungicidal Azolopyrimidines, Process for Their Preparation and Their Use For Controlling Harmful Fungi, and Also Compositions Comprising Them
06/24/2010US20100160310 2,4 (4,6) pyrimidine derivatives
06/24/2010US20100160308 Thiazolyl-Benzimidazoles
06/24/2010US20100160307 Method for controlling particular insect pests by applying anthranilamide compounds
06/24/2010US20100160306 Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
06/24/2010US20100160305 3, 4, 5 - Substituted Piperidine Compounds
06/24/2010US20100160304 Aromatic sulfone compound as aldosterone receptor modulator
06/24/2010US20100160303 Carbazole carboxamide compounds useful as kinase inhibitors
06/24/2010US20100160302 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
06/24/2010US20100160299 Dendrimer conjugates
06/24/2010US20100160292 Kinase Inhibitors, and Methods of Using and Identifying Kinase Inhibitors
06/24/2010US20100160289 Sulfonamides as trpm8 modulators
06/24/2010US20100160283 Heteroaryl-substituted alkyne compounds and method of use
06/24/2010US20100160280 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
06/24/2010US20100160255 Spiro-cyclic compound
06/24/2010US20100160247 Synthesis of deuterated morpholine derivatives
06/24/2010US20100159596 Small molecule compounds for stem cell differentiation
06/24/2010US20100158992 Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors
06/24/2010US20100158863 Triazoloanilinopyrimidine derivatives for use as antiviral agents
06/24/2010US20100158858 Administration of carboline derivatives useful in the treatment of cancer and other diseases
06/24/2010US20100155714 Organic electroluminescent device
06/24/2010US20100155706 Material for organic photoelectric device including electron transporting unit and hole transporting unit, and organic photoelectric device including the same
06/24/2010CA2747677A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
06/24/2010CA2747354A1 Organic compounds
06/24/2010CA2747252A1 Pyrazine derivatives useful as inhibitors of atr kinase
06/24/2010CA2746963A1 Isoxazole derivatives for use as plant growth regulators
06/24/2010CA2746549A1 Isoxazole derivatives for use as fungicides
06/24/2010CA2745297A1 Pyrimidin-2-ylamino derivatives and their use to treat inflammation
06/24/2010CA2744935A1 New compounds
06/24/2010CA2743397A1 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
06/23/2010EP2199287A1 Substituted isoxazoline compound and pest control agent
06/23/2010EP2199283A1 Prophylactic and/or therapeutic agent for anemia, comprising tetrahydroquinoline compound as active ingredient
06/23/2010EP2199282A1 Amide compound
06/23/2010EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors
06/23/2010EP2197877A1 3-methyl-2- ( (2s) -2- (4- (3-methyl-l, 2, 4-0xadiaz0l-5-yl) phenyl) morpholino) -6- (pyrimidin-4-yl) pyrimidin-4 (3h) -one as tau protein kinase inhibitor
06/23/2010EP2197876A1 Thiazole and oxazole kinase inhibitors
06/23/2010EP2197875A1 Diacylglycerol acyltransferase inhibitors
06/23/2010EP2197874A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use
06/23/2010EP2197873A1 Compounds and compositions as modulators of gpr119 activity
06/23/2010EP2197872A1 Phenylisoquinoline and phenylquinazoline derivatives for the treatment of bone diseases
06/23/2010EP2197859A1 Method of producing benzoxazinone-based compound
06/23/2010EP2197857A2 Insecticidal (1,3,5)-triazinyl phenyl hydrazones
06/23/2010EP2197854A1 A new class of histone deacetylase inhibitors
06/23/2010EP2197441A1 Compounds which have activity at m1 receptor and their uses in medicine
06/23/2010EP1646629B1 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
06/23/2010EP1511734B1 Compounds, compositions, and methods
06/23/2010CN1910176B Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
06/23/2010CN1906155B Novel hydroxamic acid ester derivant and pharmaceutical use thereof
06/23/2010CN1835751B Therapeutic agents useful for treating pain
06/23/2010CN101754967A benzimidazole poly(adp-ribose)polymerase inhibitors
06/23/2010CN101754966A Hepatitis c virus inhibitors
06/23/2010CN101754965A CSF-1R inhibitors, compositions, and methods of use
06/23/2010CN101754962A N-azacyclic substituted pyrrole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 for the treatment of diabetes and metabolic disorders
06/23/2010CN101747325A Neighboring Heterocyclic formanilide compound and synthesis method and application thereof
06/23/2010CN101747324A Sulfonamide derivatives
06/23/2010CN101747321A Indole-3-benzylamine derivative, preparation method and application